BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer.
Falchook GS, Millward M, Hong D, Naing A, Piha-Paul S, Waguespack SG, Cabanillas ME, Sherman SI, Ma B, Curtis M, Goodman V, Kurzrock R.
Falchook GS, et al. Among authors: kurzrock r.
Thyroid. 2015 Jan;25(1):71-7. doi: 10.1089/thy.2014.0123.
Thyroid. 2015.
PMID: 25285888
Free PMC article.